An open-label, randomized, 3-way crossover study to assess the effect of colesevelam HCl (Welchol) 3750 mg on the single dose pharmacokinetics of phenytoin sodium ER 300 mg in healthy human adult subjects.
Phase of Trial: Phase IV
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Colesevelam; Phenytoin
- Indications Epilepsy; Hypercholesterolaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Daiichi Sankyo Company
- 09 Dec 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 10 Jun 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India record.
- 15 Mar 2010 New trial record